共 50 条
The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry
被引:15
|作者:
Lee, Kyung-Jong
[1
]
Shang, Zeng-Fu
[1
,2
]
Lin, Yu-Fen
[1
]
Sun, Jingxin
[1
]
Morotomi-Yano, Keiko
[1
]
Saha, Debabrata
[1
]
Chen, Benjamin P. C.
[1
]
机构:
[1] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA
[2] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Sch Radiol & Interdisciplinary Sci,Dept Radiobiol, Suzhou, Jiangsu, Peoples R China
来源:
基金:
美国国家卫生研究院;
关键词:
DOUBLE-STRAND BREAK;
HUMAN SOMATIC-CELLS;
CYCLIN B1;
MICROTUBULE NUCLEATION;
CHROMOSOMAL STABILITY;
CANCER-THERAPY;
M-PHASE;
PHOSPHORYLATION;
PLK1;
MITOSIS;
D O I:
10.1016/j.neo.2015.02.004
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the key regulator of the non-homologous end joining pathway of DNA double-strand break repair. We have previously reported that DNA-PKcs is required for maintaining chromosomal stability and mitosis progression. Our further investigations reveal that deficiency in DNA-PKcs activity caused a delay in mitotic entry due to dysregulation of cyclin-dependent kinase 1 (Cdk1), the key driving force for cell cycle progression through G2/M transition. Timely activation of Cdk1 requires polo-like kinase 1 (Plk1), which affects modulators of Cdk1. We found that DNA-PKcs physically interacts with Plk1 and could facilitate Plk1 activation both in vitro and in vivo. Further, DNA-PKcs-deficient cells are highly sensitive to Plk1 inhibitor BI2536, suggesting that the coordination between DNA-PKcs and Plk1 is not only crucial to ensure normal cell cycle progression through G2/M phases but also required for cellular resistance to mitotic stress. On the basis of the current study, it is predictable that combined inhibition of DNA-PKcs and Plk1 can be employed in cancer therapy strategy for synthetic lethality.
引用
收藏
页码:329 / 338
页数:10
相关论文